| ABAs | aluminum-based adjuvants |
| Al | aluminum |
| ASD | autism spectrum disorder |
| ASIA | autoimmune/inflammatory syndrome induced by adjuvants |
| BBB | blood–brain barrier |
| BD | bipolar disorder |
| CDC | U.S. Centers for Disease Control and Prevention |
| CNS | central nervous system |
| CNV | copy number variant |
| GxE | gene × environment |
| HBV | hepatitis b virus |
| IL | interleukin |
| ME/CFS | myalgic encephalomyelitis/chronic fatigue syndrome |
| MIA | maternal immune activation |
| MMF | macrophagic myofasciitis |
| MMR | measles, mumps, rubella |
| mTOR | mammalian target of rapamycin |
| NNDs | neurodevelopmental disorders |
| PBMCs | peripheral blood mononuclear cells |
| SZ | schizophrenia |
| WHO | World Health Organization |